Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001739104-25-000014
Filing Date
2025-02-25
Accepted
2025-02-25 09:12:37
Documents
143
Period of Report
2024-12-31

Document Format Files

Seq Description Document Type Size
1 10-K FOR THE YEAR ENDED DECEMBER 31, 2024 elan-20241231.htm   iXBRL 10-K 2211163
2 EXHIBIT 4.5 - DESCRIPTION OF SECURITIES exhibit45-descriptionofsec.htm EX-4.5 7073
3 EXHIBIT 10.12 - ELANCO EXECUTIVE DEFERRAL AND STOCK MATCH PLAN exhibit1012-elancoanimalhe.htm EX-10.12 136361
4 EXHIBIT 10.13 - FORM OF ELANCO SIGN-ON RESTRICTED STOCK UNIT AWARD AGREEMENT exhibit1013-formofelancoan.htm EX-10.13 293276
5 EXHIBIT 10.16 - ELANCO AMENDED AND RESTATED CORPORATE BONUS PLAN exhibit1016-elancoanimalhe.htm EX-10.16 87674
6 EXHIBIT 10.22 - FORM OF ELANCO NONQUALIFIED STOCK OPTION AWARD AGREEMENT exhibit1022-formofelancoan.htm EX-10.22 104042
7 EXHIBIT 10.23 - FORM OF ELANCO RESTRICTED STOCK UNIT AWARD AGREEMENT exhibit1023-formofrestrict.htm EX-10.23 243781
8 EXHIBIT 10.24 - FORM OF ELANCO PERFORMANCE-BASED AWARD AGREEMENT exhibit1024-formofperforma.htm EX-10.24 267829
9 EXHIBIT 10.25 - ELANCO STOCK PLAN OMNIBUS AMENDMENT TO STOCK OPTION AGREEMENTS exhibit1025-elancoanimalhe.htm EX-10.25 22815
10 EXHIBIT 19 - INSIDER TRADING AND REGULATION FD POLICY exhibit19-elancoanimalheal.htm EX-19 61371
11 EXHIBIT 21.1 - SUBSIDIARIES OF ELANCO exhibit211-elancosubsidiar.htm EX-21.1 56019
12 EXHIBIT 23.1 - CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM exhibit231-consentofernsty.htm EX-23.1 3676
13 EXHIBIT 31.1 - CERTIFICATION OF CHIEF EXECUTIVE OFFICER exhibit311-ceocertificatio.htm EX-31.1 8651
14 EXHIBIT 31.2 - CERTIFICATION OF CHIEF FINANCIAL OFFICER exhibit312-cfocertificatio.htm EX-31.2 8765
15 EXHIBIT 32 - CERTIFICATIONS OF CEO AND CFO exhibit32-ceoandcfo1350cer.htm EX-32 11640
21 ELANCO LOGO elan-20241231_g1.jpg GRAPHIC 68307
22 REVENUE BY PRODUCT CATEGORY elan-20241231_g2.jpg GRAPHIC 70997
23 REVENUE BY GEOGRAPHY elan-20241231_g3.jpg GRAPHIC 60664
24 PET HEALTH GRAPHIC elan-20241231_g4.jpg GRAPHIC 15409
25 FARM ANIMAL GRAPHIC elan-20241231_g5.jpg GRAPHIC 12346
26 ITEM 5. TOTAL RETURN elan-20241231_g6.jpg GRAPHIC 108793
  Complete submission text file 0001739104-25-000014.txt   15168826

Data Files

Seq Description Document Type Size
16 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT elan-20241231.xsd EX-101.SCH 74541
17 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT elan-20241231_cal.xml EX-101.CAL 143867
18 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT elan-20241231_def.xml EX-101.DEF 484304
19 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT elan-20241231_lab.xml EX-101.LAB 1033293
20 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT elan-20241231_pre.xml EX-101.PRE 790834
146 EXTRACTED XBRL INSTANCE DOCUMENT elan-20241231_htm.xml XML 2041017
Mailing Address 2500 INNOVATION WAY GREENFIELD IN 46140
Business Address 2500 INNOVATION WAY GREENFIELD IN 46140 877-352-6261
Elanco Animal Health Inc (Filer) CIK: 0001739104 (see all company filings)

EIN.: 825497352 | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-38661 | Film No.: 25659679
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)